Clinuvel Pharmaceuticals Limited carries a market capitalization of 514.69M, placing it among publicly traded companies globally.
| Market Cap | 514.69M |
| Enterprise Value | N/A |
Clinuvel Pharmaceuticals Limited's stock has gained approximately 1.1893% over the past 52 weeks. The 50-day moving average sits at 9.44, while the 200-day moving average is 10.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.1893% |
| 50-Day Moving Average | 9.44 |
| 200-Day Moving Average | 10.80 |
| Average Volume (20 Days) | N/A |
Clinuvel Pharmaceuticals Limited's most recent stock split took place on November 11, 2010 with a 10:1 split ratio.
| Last Split Date | 11/11/2010 |
| Split Ratio | 10:1 |